Company Ropharma Sa with Fiscal Code 1962437
recorded a turnover of 2024 of
213.713.191,
with a net profit of
1.326.615
and having an average number of employees of
1033.
The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Ropharma Sa
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
76.111.157
74.627.342
86.760.194
105.572.918
92.748.971
94.884.379
111.648.413
122.395.131
213.713.191
Total Income - EUR
-
78.203.490
76.153.257
88.893.007
107.645.336
94.296.897
98.361.136
114.334.639
124.425.410
217.071.666
Total Expenses - EUR
-
76.382.737
74.551.220
87.104.113
106.240.901
92.798.383
96.897.624
112.671.138
122.637.437
213.530.700
Gross Profit/Loss - EUR
-
1.820.753
1.602.037
1.788.895
1.404.435
1.498.514
1.463.512
1.663.500
1.787.973
3.540.965
Net Profit/Loss - EUR
-
1.623.485
1.333.909
1.529.437
1.229.640
1.271.637
1.351.577
1.435.535
1.692.031
1.326.615
Employees
-
726
745
727
747
727
711
718
724
1.033
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 75.6%, from 122.395.131 euro in the year 2023, to 213.713.191 euro in 2024.
The Net Profit decreased by -355.960 euro, from 1.692.031 euro in 2023, to 1.326.615 in the last year.
Check the financial reports for the company - Ropharma Sa
Financial Rating - ROPHARMA SA
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Ropharma Sa
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Ropharma Sa
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Ropharma Sa
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Ropharma Sa - CUI 1962437
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
-
27.262.412
30.089.821
40.071.265
52.624.807
50.450.927
50.492.693
54.324.317
57.098.094
69.557.155
Current Assets
-
20.287.562
22.908.945
36.270.354
47.374.469
38.437.870
35.744.211
44.721.134
44.621.272
115.410.400
Inventories
-
8.094.898
8.472.708
7.166.791
11.900.401
12.074.209
11.291.996
13.643.449
15.478.992
46.305.737
Receivables
-
8.276.473
12.959.534
27.678.878
34.107.385
24.584.825
23.398.201
29.485.967
27.314.717
66.159.896
Cash
-
3.916.191
1.476.703
1.424.684
1.366.683
1.778.836
1.054.014
1.591.718
1.827.563
2.944.767
Shareholders Funds
-
30.373.207
31.812.646
33.156.286
34.004.761
36.158.938
37.381.849
39.893.462
42.538.235
44.429.521
Social Capital
-
15.297.634
15.038.773
13.879.558
10.773.958
10.569.709
10.335.316
10.367.381
10.335.943
10.278.178
Debts
-
17.247.320
21.294.739
43.268.500
66.114.689
52.728.655
48.990.724
59.251.996
59.346.997
140.792.972
Income in Advance
-
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"4773 - 4773"
CAEN Financial Year
4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
115.410.400 euro in 2024 which includes Inventories of
46.305.737 euro, Receivables of
66.159.896 euro and cash availability of
2.944.767 euro.
The company's Equity was valued at
44.429.521 euro, while total Liabilities amounted to
140.792.972 euro.
Equity increased by 2.129.020 euro, from 42.538.235 euro in 2023, to 44.429.521 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ropharma Sa